糖心原创

Trust our team to support 
your transition to human cells

Moving to human iPSC-derived cells is a big step, but you don鈥檛 take it alone. From finding funding opportunities and relevant events, to clear user manuals, optimised application protocols, and responsive, hands-on technical support, we鈥檙e with you every step of the way. 

Reach out to start your journey and join the community of scientists advancing the adoption of human cells. 

How to get started with human cells
How to get started with human cells

Understanding and applying human iPSC-derived cells

Get support for your research

Funding opportunities to support the reduction and replacement of animal research across the UK, Europe, the US and Canada.

 

Region Funding Body Funding Type / Purpose Grant / Prize Size Deadline  Additional info
UK Animal welfare / 3R projects (refinement, replacement, education, publications) Substantial awards (over 拢3,500) for major projects Anytime (with at least 2 months鈥 lead before project start) Good for small-scale/ medium-scale 3R or welfare-related studies
UK Animal welfare / 3R projects (refinement, replacement, education, publications) Smaller grants via Small Project / Travel Awards for < 拢3,500 Anytime (with at least 2 months鈥 lead before project start) Good for small-scale/ medium-scale 3R or welfare-related studies
UK Animal-free biomedical research project grants and fellowships ~ 拢90,000 - 拢200,000 Project-grant call opens 2 Feb 2026; closes 24 May 2026 Supports fully animal-free disease-focused research.
UK Innovation Grants (pilot studies) Small grants ~ 拢5,000 2025 round closed; next call not yet announced for 2026 Supports proof-of-principle animal-free method development.
Germany Research / young-researcher award in systems medicine / 3R-relevant biomedical research 鈧15,000 31-Jan-26 Suitable for system-oriented health / biomedical projects with 3R relevance
Germany Molecular-biology research on disease mechanisms (cell and/or human tissue-based, could partly involve animal models but requires human tissue/cell component) Not specified 01-Feb-26 Could fit human iPSC / cell-based disease-mechanism modelling
Germany Funding for alternative (non-animal) methods: replacement, validation, dissemination of 3R-methods Not specified 15-Mar-26 Directly relevant to non-animal / replacement method development
Germany Research or welfare-oriented work aimed at replacing or reducing animal testing, or improving animal welfare in labs Up to 鈧30,000 30 Sep 2026 Good for substantial projects in replacement/  refinement/ welfare
Europe   Support research groups that have demonstrated an ongoing commitment to the adoption of human-specific research. Not specified Coming soon in 2026  
Europe Grants for young scientists to develop/test Replacement, Reduction and/or Refinement methods (3R projects) 鈧 3,000 For projects starting 2026; application deadline 31 Oct 2025 (4 pm CET) Good entry-level funding for 3R method development
Europe Grants for science communication / outreach / transparency related to animal research / 3R awareness / tools & resources Up to 鈧3,000 For projects starting 2025; application deadline 31 Oct 2025  Useful for educational / outreach / science-communication 3R initiatives
USA Annual Open Grant Program Up to $50,000 Next call expected early 2026 Supports the development of non-animal research/testing methods.
USA Research grants supporting development of non鈥慳nimal methods Up to $40,000 Annual cycles; ongoing into 2026 Supports in vitro assays, AOP development, and mechanistic toxicology
USA Reduction-focused research (meta鈥慳nalysis, reproducibility, model reevaluation) Varies Available; 2025/26 cycle active or recurring Supports projects evaluating the limitations of animal models
USA Development of animal鈥慺ree teaching and training resources ~$6,000 Available; recurring annually Supports the creation of human鈥憆elevant training tools

 

Learn from your peers

Here are some of the top conferences and events to attend to learn about how peers are utilising human iPSC-derived cells and new techniques being developed to support the integration of iPSC-derived cells.

Conference Dates Location
Feb 4鈥5 2026 Cambridge, UK
Feb 7鈥11 2026 Boston, MA, USA
Feb 12鈥13 2026 Oslo, Norway
Mar 10鈥12 2026 Raleigh, NC, USA
Mar 22鈥25 2026 San Diego, CA, USA
Mar 24鈥27 2026 T眉bingen, Germany
Apr 17鈥22 2026 San Diego, CA, USA
Apr 20鈥24 2026 Palma, Spain
May 7鈥8 2026 London, UK
May 19鈥21 2026 Vienna, Austria
May 26鈥29 2026 Washington, D.C., USA
Jun 22鈥24 2026 Braga, Portugal
Jun 29 鈥 Jul 2 2026 Maastricht, NL
Jul 8鈥11 2026 Montreal, Canada
Nov 14鈥18 2026 Washington, D.C., USA
Dec 12鈥16 2026 San Diego, CA, USA

 

Flexible training options: join us virtually or in person

Tutorial video microglia email card
_LM03612-Edit_RT HR (1)
糖心原创_we_re_human_Pic0006
_LM04815-Edit_RT HR (1)
We provide support at every step, from protocols and video tutorials to virtual and in-person lab training.

Master your workflows with our protocol library

Explore a comprehensive collection of optimised protocols for standard cell culture and advanced iPSC applications. From optimising human iPSC-derived cells in high-throughput multiwell formats to managing complex multi-cell cultures, our library provides the precise steps needed for reliable assays and specialised applications.

To get your lab up and running with human iPSC-derived ioCells, you will need the following equipment.

Equipment Necessity Reason
Class II Biosafety Cabinet Required Protects cells from contamination and you from human pathogens.
Liquid nitrogen storage Required  -80掳C is for short-term (days) only; liquid nitrogen is for long-term.
Automated cell counter Highly recommended
Vital for plating exact densities (e.g. neurons and microglia are sensitive to 'crowding').
Water bath  Required
Essential for rapid thawing at 37掳C. When using water bath, meticulously clean it weekly to prevent "water-to-hood" contamination. 
Centrifuge Required Must have a swing-bucket rotor and adjustable "braking" speeds to prevent mechanical stress on fragile cells.
Pipettes Required Use high-precision P1000/P200 sets. Ergonomic electronic pipettes are preferred for "slow-dispense" modes.
Phase contrast microscope Required Vital for daily monitoring of attachment, health, and potential contamination.

 

Do I need a specialised incubator?

No, a standard 37oC, 5% CO2 incubator works fine. You will need to incorporate strict rules for cleanliness and humidity management, as iPSC-derived cells can be in culture for a long time (weeks to months). 

Cleanliness 

  • Antimicrobial surfaces: An incubator with a solid copper interior is highly preferred. Copper has natural contact-killing properties that continuously suppress bacterial and fungal growth.
  • Decontamination cycles: Look for models with a High-Heat Sterilisation cycle (typically 140oC to 180oC). You should run this cycle before starting a new culture to ensure a 'sterile baseline.'

Humidity management

Because these cultures stay in the incubator for long periods, even tiny amounts of evaporation can be fatal.

  • Salt spikes: As water evaporates from your media, the concentration of salts and minerals increases (increasing osmolarity). Neurons are incredibly sensitive to this and will stop firing or detach.

To prevent increased osmolarity, ensure your incubator has a high-quality water pan (using sterile, ultra-pure water with an antimicrobial additive like Aquaguard) and minimise door-opening frequency to keep humidity at 95%.

How do I store human iPSC-derived cells?

The cell must be store in liquid nitrogen. 

Never store iPSC-derived cells in a -80oC freezer for longer than 24 hours. Even a "stable" -80oC can fluctuate, causing microscopic ice recrystallisation that kills post-mitotic cells.

The vapour phase of liquid nitrogen (-150oC to -190oC) is preferred over immersion to avoid the rare risk of "exploding vials" or cross-contamination through the vial caps.

What biosafety requirements should I consider for commercial human iPSC-derived cells?

Containment Level: Commercial human iPSC-derived cells are handled under Biosafety Level 2 (BSL-2) containment. Even if the cells are "commercial," human-derived materials are treated as potentially infectious for bloodborne pathogens.

Cabinet Requirements: All cell handling, such as thawing, culture, and dissociation, should be performed in a Class II biological safety cabinet.

Personal Protective Equipment (PPE): Safety glasses, lab coats, and gloves must be worn to prevent exposure to skin, eyes, or mucous membranes.

Is my Cat 2 hood enough?

Yes, a Class II Biosafety Cabinet (BSC) is the right equipment. A Class II BSC protects both the product (from your breath/dust) and the user (from aerosols).

Let鈥檚 work together for human-specific research

Hear from our community who are driving science forward.

Mariangela iovino were human interview 1 (1)

Mariangela Iovino, PhD
Senior Group Leader
Charles River Laboratories

Building connections with Dr Mariangela Iovino, discussing how industry experts are incorporating human cells to drive human-specific drug discovery.

Eric Hill were human interview 1

Eric Hill, PhD
Reader in Cellular and Molecular Neurobiology
Loughborough University

In conversation with Dr Eric Hill we cover pushing the boundaries, culturing human neurons on a computer chip, and making AI sustainable.

Ross dobie 3

Ross Dobie, PhD
Head of Science
Centre for Human Specific Research

Dr Ross Dobie explores the move to human models, covering adoption hurdles, scientific and cost challenges, supportive FDA and NIH policies, and the rise of NAMs.

Book a call with our experts 

Getting ready to dive into human iPSC-derived cells?
Our team is here to guide you every step of the way.


 

The scientists driving the future of human cell-based research

An image of Dr Michael Duchen

Dr Michael Duchen

Professor of Physiology | University College London

鈥淲e can now start asking questions that, ten years ago, we didn鈥檛 know how to answer,鈥 Duchen reflects. 鈥淚f you have a really good disease model, then the only limit is your imagination.鈥

An image of Jeremy Krohn

Jeremy Krohn

PhD Candidate | DZNE / Charit茅 University of Medicine

"We used 糖心原创 human ioAstrocytes in our experiments to compare with - and step-wise replace - animal derived cells. The human cells were straightforward to establish, showed high reproducibility, and performed well in calcium imaging experiment."

An image of Dr Marijn Vlaming

Dr Marijn Vlaming

Head of Biology - Beerse & Leiden | Charles River

"Using more relevant cell models such as ioCells from 糖心原创 helps us to test safety and toxicity in vitro, in parallel with efficacy, and as such we will be able to identify the safe or unsafe drug candidates very early in the drug discovery process"

An image of Matteo Zanella, PhD

Matteo Zanella, PhD

Associate Research Leader | Charles River

"At Charles River we used 糖心原创 ioMicroglia in several projects. We are very satisfied with their performances, as they efficiently and robustly recapitulate both morphological and functional properties of microglia cells"

An image of Dr Alessandra Pagliaro

Dr Alessandra Pagliaro

Research scientist | In Vitro Biology | Evotec

"With our solid iPSC expertise, we were thrilled to find a cellular model that aligns seamlessly with our drug screening efforts. ioOligodendrocyte-like cells performed reliably and met all expectations. We especially appreciated 糖心原创's detailed protocols and excellent scientific support, which made integration into our workflow both smooth and productive."

Move forward with consistent ioCells for translational results

ioSkeletal Myocytes_for partners module

ioWild Type Cells

ioWild Type Cells are defined, easy-to-use, functional iPSC-derived human cells from a healthy donor background that are ready for fundamental research and drug discovery experimentation within days.

Discover ioCells portfolio ICC ioDisease model cells

ioDisease Model Cells

ioDisease Model Cells are ioWild Type Cells engineered to contain disease-relevant mutations. ioDisease Model Cells and ioWild Type Cells form an isogenic pair allowing scientists to make true comparisons.

bb-CRISPR-ready-card

CRISPR-Ready ioCells

CRISPR-Ready ioCells are human iPSC-derived cells constitutively expressing Cas9 nuclease for rapid gene knockout generation. 

bb-iotracker-cards

ioTracker Cells

ioTracker Cells are human iPSC-derived cells constitutively expressing a fluorescent protein for easy visualisation, tracking, and isolation of human cells in live-cell imaging assays.

Related pages

Discover ioCells Learn about our range of human iPSC-derived cells for research and drug discovery
Resources Explore our latest scientific insights, webinars, blogs and videos
Our platform Discover the cell identity coding platform behind our cells